(19)
(11) EP 3 496 636 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
24.01.2024 Bulletin 2024/04

(45) Mention of the grant of the patent:
13.12.2023 Bulletin 2023/50

(21) Application number: 17840294.7

(22) Date of filing: 10.08.2017
(51) International Patent Classification (IPC): 
A61B 17/56(2006.01)
A61B 17/68(2006.01)
A61B 17/86(2006.01)
A61F 2/28(2006.01)
A61F 2/44(2006.01)
B29L 31/00(2006.01)
A61B 17/58(2006.01)
A61B 17/70(2006.01)
A61F 2/00(2006.01)
A61F 2/30(2006.01)
B33Y 80/00(2015.01)
(52) Cooperative Patent Classification (CPC):
B29C 64/153; A61F 2/4425; A61F 2002/3023; A61F 2002/30568; B33Y 10/00; B33Y 80/00; A61F 2002/30841; A61F 2210/0014; A61F 2310/00023; A61F 2310/00029; B29L 2031/7532
(86) International application number:
PCT/US2017/046339
(87) International publication number:
WO 2018/031801 (15.02.2018 Gazette 2018/07)

(54)

INTERVERTEBRAL DISC REPLACEMENT

BANDSCHEIBENERSATZ

REMPLACEMENT DE DISQUE INTERVERTÉBRAL


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 11.08.2016 US 201615234923

(43) Date of publication of application:
19.06.2019 Bulletin 2019/25

(73) Proprietor: Agada Medical Ltd.
Ramat Hasharon (IL)

(72) Inventors:
  • YADIN, Annon
    Kfar Vitkin (IL)
  • LIEBERMAN, Isador Harry
    Plano, Texas 75093 (US)
  • DAGAN, Adi
    Zichron Yaakov (IL)
  • FLEISCHMANN, Yoram
    Lehavot-Haviva (IL)

(74) Representative: Crease, Devanand John et al
Keltie LLP No.1 London Bridge
London SE1 9BA
London SE1 9BA (GB)


(56) References cited: : 
WO-A1-2017/100366
US-A- 4 759 769
US-A1- 2005 113 924
US-A1- 2006 200 239
US-A- 4 759 769
US-A1- 2002 128 714
US-A1- 2006 149 381
US-A1- 2012 016 480
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).